Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
<http://hl7.org/fhir/Library/179632> a fhir:Library ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "179632"] ; #
fhir:meta [
fhir:versionId [ fhir:v "4" ] ;
fhir:lastUpdated [ fhir:v "2023-12-15T13:02:51.862Z"^^xsd:dateTime ] ;
fhir:profile ( [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/systematic-review-excluded-studies"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/systematic-review-excluded-studies>
] )
] ; #
fhir:language [ fhir:v "en"] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <table class=\"narrative-table\">\n <tbody>\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">Metadata</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">SystematicReviewExcludedStudies: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Version</th>\n\n\n\n<td class=\"content-container\">1.0.0-ballot3</td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">179632</td>\n\n\n</tr>\n\n\n \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">urn:oid:2.16.840.1.113883.4.642.40.44.28.2</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Subject Type</th>\n\n\n\n<td class=\"content-container\"><a href=\"Group-179619.html\">SystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer</a></td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Use Context</th>\n\n\n\n<td class=\"content-container\">\n Evidence Communication\n\n = \n SystematicReviewExcludedStudies\n\n\n</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Jurisdiction</th>\n\n\n\n<td class=\"content-container\">\n World\n\n\n</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward (Publisher)</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Decision Support</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward Contact</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Decision Support</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Developer</th>\n\n\n\n<td class=\"content-container\">Brian S. Alper</td>\n\n\n</tr>\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\"><div><p>11 excluded studies</p>\n</div></td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Copyright</th>\n\n\n\n<td class=\"content-container\"><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div></td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Type</th>\n\n\n\n<td class=\"content-container\">\n Asset Collection\n\n\n</td>\n\n\n</tr>\n\n\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\"><a name=\"parameters\"> </a>Parameters</th>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Parameter</th>\n\n\n\n<td class=\"content-container\">None</td>\n\n\n</tr>\n\n\n\n\n\n\n\n<tr>\n <th colspan=\"2\" scope=\"row\" class=\"row-header\">Generated using version 0.5.4 of the sample-content-ig Liquid templates</th>\n</tr>\n\n </tbody>\n </table>\n</div>"^^rdf:XMLLiteral ]
] ; #
fhir:extension ( [
fhir:url [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status>
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/cited-artifact-status-type>
] ;
fhir:code [ fhir:v "active" ] ;
fhir:display [ fhir:v "Active" ]
] )
]
] ) ; #
fhir:url [
fhir:v "https://fevir.net/resources/Library/179632"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/Library/179632>
] ; #
fhir:identifier ( [
fhir:type [
fhir:coding ( [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/v2-0203>
] ;
fhir:code [ fhir:v "ACSN" ] ;
fhir:display [ fhir:v "Accession ID" ]
] ) ;
fhir:text [ fhir:v "FEvIR Object Identifier" ]
] ;
fhir:system [
fhir:v "https://fevir.net/FOI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FOI>
] ;
fhir:value [ fhir:v "179632" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]
]
] [
fhir:system [
fhir:v "urn:ietf:rfc:3986"^^xsd:anyURI ;
fhir:l <urn:ietf:rfc:3986>
] ;
fhir:value [ fhir:v "urn:oid:2.16.840.1.113883.4.642.40.44.28.2" ]
] ) ; #
fhir:version [ fhir:v "1.0.0-ballot3"] ; #
fhir:title [ fhir:v "SystematicReviewExcludedStudies: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:experimental [ fhir:v false] ; #
fhir:type [
fhir:coding ( [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/library-type"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/library-type>
] ;
fhir:code [ fhir:v "asset-collection" ] ;
fhir:display [ fhir:v "Asset Collection" ]
] )
] ; #
fhir:subject [
a fhir:Reference ;
fhir:l <http://hl7.org/fhir/Group/179619> ;
fhir:reference [ fhir:v "Group/179619" ] ;
fhir:type [
fhir:v "Group"^^xsd:anyURI ;
fhir:l fhir:Group
] ;
fhir:display [ fhir:v "SystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer" ]
] ; #
fhir:date [ fhir:v "2023-11-26T18:15:27.442Z"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "HL7 International / Clinical Decision Support"] ; #
fhir:contact ( [
fhir:name [ fhir:v "HL7 International / Clinical Decision Support" ] ;
fhir:telecom ( [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://www.hl7.org/Special/committees/dss" ]
] )
] ) ; #
fhir:description [ fhir:v "11 excluded studies"] ; #
fhir:useContext ( [
fhir:code [
fhir:system [
fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/CodeSystem/179423>
] ;
fhir:code [ fhir:v "evidence-communication" ] ;
fhir:display [ fhir:v "Evidence Communication" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [
fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/CodeSystem/179423>
] ;
fhir:code [ fhir:v "SystematicReviewExcludedStudies" ] ;
fhir:display [ fhir:v "SystematicReviewExcludedStudies" ]
] )
]
] ) ; #
fhir:jurisdiction ( [
fhir:coding ( [
fhir:system [
fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ;
fhir:l <http://unstats.un.org/unsd/methods/m49/m49.htm>
] ;
fhir:code [ fhir:v "001" ] ;
fhir:display [ fhir:v "World" ]
] )
] ) ; #
fhir:copyright [ fhir:v "https://creativecommons.org/licenses/by-nc-sa/4.0/"] ; #
fhir:author ( [
fhir:name [ fhir:v "Brian S. Alper" ]
] ) ; #
fhir:relatedArtifact ( [
fhir:type [ fhir:v "derived-from" ] ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179613> ;
fhir:reference [ fhir:v "Citation/179613" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "27308831 Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Different comparison (ADT versus ADT plus estramustine)" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179628> ;
fhir:reference [ fhir:v "Citation/179628" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "14706014 Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Different comparison (ADT versus ADT plus chemotherapy without docetaxel)" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179631> ;
fhir:reference [ fhir:v "Citation/179631" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "19029421 Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Different comparison (ADT versus ADT plus radiotherapy)" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179627> ;
fhir:reference [ fhir:v "Citation/179627" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "19091394 Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Different comparison (ADT versus ADT plus radiotherapy)" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179626> ;
fhir:reference [ fhir:v "Citation/179626" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "22056152 Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Different comparison (ADT versus ADT plus radiotherapy)" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179625> ;
fhir:reference [ fhir:v "Citation/179625" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "22502942 Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Nonrandomized" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179629> ;
fhir:reference [ fhir:v "Citation/179629" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "23604530 A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Neoadjuvant treatment" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179624> ;
fhir:reference [ fhir:v "Citation/179624" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "24598155 Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Nonrandomized" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179622> ;
fhir:reference [ fhir:v "Citation/179622" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "26002607 Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "High-risk localized prostate cancer" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179621> ;
fhir:reference [ fhir:v "Citation/179621" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "26028518 Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Locally advanced or metastatic (without metastatic subgroup analysis)" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179630> ;
fhir:reference [ fhir:v "Citation/179630" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "26092557 Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer." ]
]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:classifier ( [
fhir:text [ fhir:v "Nonrandomized" ]
] ) ;
fhir:resourceReference [
fhir:l <http://hl7.org/fhir/Citation/179623> ;
fhir:reference [ fhir:v "Citation/179623" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation
] ;
fhir:display [ fhir:v "23452809 Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer." ]
]
] ) . #
<http://hl7.org/fhir/Group/179619> a fhir:Group .
<http://hl7.org/fhir/Citation/179613> a fhir:Citation .
<http://hl7.org/fhir/Citation/179628> a fhir:Citation .
<http://hl7.org/fhir/Citation/179631> a fhir:Citation .
<http://hl7.org/fhir/Citation/179627> a fhir:Citation .
<http://hl7.org/fhir/Citation/179626> a fhir:Citation .
<http://hl7.org/fhir/Citation/179625> a fhir:Citation .
<http://hl7.org/fhir/Citation/179629> a fhir:Citation .
<http://hl7.org/fhir/Citation/179624> a fhir:Citation .
<http://hl7.org/fhir/Citation/179622> a fhir:Citation .
<http://hl7.org/fhir/Citation/179621> a fhir:Citation .
<http://hl7.org/fhir/Citation/179630> a fhir:Citation .
<http://hl7.org/fhir/Citation/179623> a fhir:Citation .
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-ballot3.
Generated
2026-06-26
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change